Korean Observational Study to Evaluate the Efficacy and Safety of Anagliptin Switching From Other DPP4is in type2 DM
NCT04267601 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 2448
Last updated 2021-04-29
Summary
This study was designed as a non-interventional, single-group, open-label, multicenter observational study for patients with type 2 diabetes in the real world clinical setting.
Conditions
Interventions
- DRUG
-
Anagliptin
Anagliptin treatment for 24weeks
Sponsors & Collaborators
- lead INDUSTRY
Eligibility
- Min Age
- 19 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-07-06
- Primary Completion
- 2021-03-30
- Completion
- 2021-09-30
Countries
- South Korea
Study Locations
More Related Trials
-
Efficacy and Safety of CWP-0403 Compared to Sitagliptin in Patients With Type 2 Diabetes Mellitus Insufficiently Controlled With Metformin Alone
NCT01529541 ·Status: COMPLETED ·Phase: PHASE3
-
Compare the Effect of DPP-IV Inhibitor or TZD on Glycemic Variability and Oxidative Stress in Patient With 2 Diabetes
NCT01339143 ·Status: UNKNOWN ·Phase: PHASE4
-
Pharmacodynamics of Mitiglinide/Sitagliptin Compared to Mitiglinide and Sitagliptin
NCT01422590 ·Status: COMPLETED ·Phase: PHASE1
-
Teneligliptin Versus Linagliptin in Diabetes Mellitus Type Two Patients
NCT03011177 ·Status: COMPLETED ·Phase: PHASE4
-
Predictive Parameters for Efficacy of Sitagliptin and Metformin Combination
NCT00969566 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Efficacy, Weight Control, and Safety in Newly-diagnosed Type 2 Diabetes With Different Antidiabetic Therapy
NCT03700801 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of VIldagliptin aS an Add-on Therapy to Metformin Compared to Metformin Up-TitratION in Chinese Patients With Type 2 Diabetes.(VISION)
NCT01541956 ·Status: COMPLETED ·Phase: PHASE4
-
The Efficacy of Sodium-glucose Co-transporter 2 Inhibitor or Dipeptidyl Peptidase-4 Inhibitor in Type 2 Diabetes Patients With Premix Insulin
NCT03458715 ·Status: UNKNOWN ·Phase: PHASE4
-
Effect of Dipeptidyl Peptidase-IV Inhibitor and Sulfonylurea on Glucose Variability and Oxidative Stress
NCT00699322 ·Status: UNKNOWN ·Phase: PHASE4
-
Effects of Sitagliptin on Type 2 Diabetes Mellitus Patients on Treatment With Metformin and Insulin
NCT01341717 ·Status: COMPLETED ·Phase: PHASE4
-
Safety of Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors Among Patients with Type 2 Diabetes
NCT04017221 ·Status: COMPLETED
-
Effect of Empagliflozin on Body Composition and Ketones
NCT03877406 ·Status: UNKNOWN ·Phase: PHASE4
-
Sitagliptin Versus Glipizide in Participants With Type 2 Diabetes Mellitus and Chronic Renal Insufficiency (MK-0431-063 AM1)
NCT00509262 ·Status: COMPLETED ·Phase: PHASE3
-
DPP4 Inhibitor on Glycemic Variability
NCT04654676 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy of Sitagliptin Added to Insulin Therapy for Type 2 Diabetes
NCT01855087 ·Status: COMPLETED
-
Sulfonylurea Response in Patients With Diabetes Due to Kir6.2 Mutations
NCT00334711 ·Status: COMPLETED ·Phase: NA
-
The Effect of Vildagliptin Based Treatment Versus Sulfonylurea on Glycemic Variability, Oxidative Stress, GLP-1, and Endothelial Function in Patients With Type 2 Diabetes
NCT01404676 ·Status: COMPLETED ·Phase: PHASE4
-
Triple Combination Therapy in Type 2 Diabetic Patients Who Had Inadequate Glycemic Control With Combination Therapy
NCT02338921 ·Status: COMPLETED ·Phase: PHASE4
-
A Study in Type 2 Diabetics of Single and Multiple Doses of Orally Administered GSK1292263 to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics
NCT01119846 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety Study of Linagliptin (5 mg Administered Orally Once Daily) Over 24 Weeks, in Drug naïve or Previously Treated Type 2 Diabetic Patients With Insufficient Glycaemic Control
NCT01214239 ·Status: COMPLETED ·Phase: PHASE3
-
Randomized Evaluation of Anagliptin Versus Sitagliptin On Low-density lipoproteiN Cholesterol in Diabetes Trial
NCT02330406 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Study on Sitagliptin for Assessment of Glucose-lowering Effects (0431-045)
NCT00758069 ·Status: COMPLETED ·Phase: PHASE2
-
Regimen Transition After Short-Term Intensive Insulin Therapy in Type 2 Diabetes
NCT07173712 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Using of SGLt2 Inhibitors in Patients With Type 2 DM
NCT06268977 ·Status: NOT_YET_RECRUITING
-
Sitagliptin Mechanism of Action Study in Patients With Type 2 Diabetes Mellitus (0431-059)
NCT00704132 ·Status: COMPLETED ·Phase: PHASE1